Click here to read the articles and download the PDF

Pharmaceutical Commerce - August 2022

While companies in this space are grappling with issues ranging from inflation and supply chain disruption to workforce scarcity and DSCSA implementation, there’s still plenty of room for smaller players to stake out part of the terrain to call their own

Pharma Distribution: Carving New Ground

Exploring the competitive and unique offerings in three of the US’s lower-cost economic development regions—and how success in these areas has been boosted by COVID

Regions On Rise: Life Sciences Across US

A look into one of the East Coast’s major life science hubs

Tapping Industry’s Reach in Maryland

Articles

Company’s 344,000 square-foot facility revolves around pharma and medical items

DHL Supply Chain Adds New Logistics Center in Germany

Partnership adds technological offerings to PharmaLex’s repertoire 

PharmaLex Expands Nordic Presence, Merges with DRA Consulting

Thermo Fisher’s Dean Rainbolt on how ultra low-temperature freezers are continuing to change the game

A Dive into ULT

Site expected to boost the CDMO’s global drug production capabilities

WuXi STA Breaks Ground on New Pharma Manufacturing Site in Delaware

is Chicago office chair of the Health Law Practice Group at the law firm, Quarles & Brady LLP. She advises a range of health care clients on regulatory and transactional matters, including assisting pharmacy and wholesale distributors in developing regulatory compliance strategies.

 is a partner at Quarles & Brady. He uses his extensive experience as an attorney representing pharmacies, pharmacists and other health care providers – along with his background as a pharmacist – to advise on regulatory compliance and defend clients in litigation matters.

is an associate at Quarles & Brady. He has extensive experience with the 340B Drug Pricing Program and also regularly assists pharmacy benefit managers (PBMs), utilization review agents (URAs) and third-party administrators (TPAs) in navigating the complex and evolving regulatory landscape facing these entities.

As a result of the United States Supreme Court’s overturning of Roe v. Wade and Planned Parenthood v. Casey, pharmacy providers are looking to state laws and other recently issued federal guidance in determining how they can compliantly meet patient needs and deliver medications.

Navigating Abortion Restrictions Post Dobbs: Considerations for Pharmacy Providers

Three of the authors of a new EY study exploring the evolution of industry supply chain strategies and the long-term implications for healthcare delivery across three major trade regions discuss the report’s key findings and share their predictions as we move into Q3

New Report Looks to the Supply Chains of the Future

The shot targets the original variant, along with Omicron

UK Approves First Bivalent COVID-19 Booster Vaccine

Agreement is centered around expanding medication access to patients

ScriptDrop, Roadie Strengthen Delivery Partnership

In deal to be finalized by October, purchases B Medical Systems for $423 million

Azenta Acquires Cold Chain Manufacturer

Growth of CDMO's Pennsylvania facility will feature increase in cold chain storage capacity

Featured Content

Pharmaceutical Commerce - August 2022

Pharma Distribution: Carving New Ground

Regions On Rise: Life Sciences Across US

Tapping Industry’s Reach in Maryland